Sort   by:  
 Page size 
TranscriptomicsCircadian regulation of gene expression in the coral algal endosymbiosis
Despite their early evolutionary divergence, reef-building corals exhibit complex circadian responses to diurnal, lunar and annual changes in the conditions around them. Understanding circadian regulation in reef-building corals is, however, complicated by the presence of photosynthetic endosymbiont...
ORGANISM(S): Acropora millepora 
2011-04-20 | E-GEOD-21658 | biostudies-arrayexpress
UnknownFast neurotransmission related genes are expressed in non nervous endoderm in the sea anemone Nematostella vectensis.
Not available
S-EPMC3976352 | biostudies-literature
UnknownProfiling molecular and behavioral circadian rhythms in the non-symbiotic sea anemone Nematostella vectensis.
Not available
S-EPMC4476465 | biostudies-literature
UnknownGp96 Peptide Antagonist gp96-II Confers Therapeutic Effects in Murine Intestinal Inflammation.
Not available
S-EPMC5732239 | biostudies-literature
UnknownEvaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.
Not available
S-EPMC8531466 | biostudies-literature
UnknownPeptides modulating conformational changes in secreted chaperones: from in silico design to preclinical proof of concept.
Not available
S-EPMC2728974 | biostudies-literature
ProteomicsLymphodepleting chemotherapy potentiates neoantigen-directed T-cell therapy by enhancing antigen presentation
Adoptive cell therapy (ACT) targeting tumor-specific antigens holds promise for solid-tumors, but limited neoantigen presentation remains a key barrier to efficacy. Here, we identify and characterize a T-cell receptor (TCR), T104, for the KRAS.G12V mutation, a prevalent neoantigen in colorectal, lun...
ORGANISM(S): Homo sapiens (Human) 
2026-01-12 | PXD070607 | Pride
Kras g12v Lymphodepleting chemotherapy Proteomics Kras g12c Tcr therapy Neoantigens Colon cancer. Adoptive cell therapy Immunotheraphy Pancreatic cancer 
ProteomicsTCR targeting of KRAS G12V/C neoantigens is enhanced by lymphodepleting chemotherapy
Lung cancer remains the leading cause of cancer-related deaths worldwide. Immunotherapy agents have doubled treatment response rates in non-small cell lung cancer (NSCLC). However, these responses are neither universal nor consistently durable, underscoring the need for innovative therapeutic strate...
ORGANISM(S): Homo sapiens (Human) 
2025-10-03 | PXD061178 | Pride
Lymphodepleting chemotherapy Lung cancer Kras g12v Kras g12c Tcr therapy Neoantigens Colon cancer. Adoptive cell therapy Pancreatic cancer 
UnknownMonkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022.
Not available
S-EPMC9438394 | biostudies-literature
UnknownTemporal genomic analysis of melanoma rejection identifies regulators of tumor immune evasion.
Not available
S-EPMC10705560 | biostudies-literature
Sort   by:  
 Page size